US stock futures dip as Trump’s firing of Cook sparks Fed independence fears
Robert DeSantis, Executive Vice President and Chief Strategy & Corporate Operations Officer at Intuitive Surgical Inc . (NASDAQ:ISRG), recently sold shares worth approximately $5.76 million, according to a Form 4 filing with the Securities and Exchange Commission. The transactions took place on March 13, 2025.
DeSantis executed several transactions involving the sale of common stock, with prices ranging between $498.71 and $500.00 per share. In total, he sold 11,565 shares.
In addition to the sales, DeSantis exercised non-qualified stock options, acquiring shares at prices ranging from $208.9 to $347.4167 per share, amounting to a total of $891,640.
These transactions were carried out under a pre-established trading plan compliant with SEC Rule 10b5-1, set to expire on December 12, 2025. Following these transactions, DeSantis holds 5,224 shares directly.
In other recent news, Intuitive Surgical reported a robust fourth-quarter performance, exceeding expectations with a 10% revenue beat and a 24% earnings per share (EPS) beat. The company also achieved a significant 38% year-over-year increase in EPS to $2.21, surpassing the consensus estimate by 22%. Intuitive Surgical’s procedure volume grew by 18% year-over-year, and the company has projected a 13-16% increase for 2025. The anticipated mid-2025 launch of the da Vinci (EPA:SGEF) 5 system is expected to drive future growth. Analysts from RBC Capital Markets, Piper Sandler, and Bernstein have maintained positive ratings on the company, with price targets set at $641, $670, and $700, respectively. Despite concerns about gross margins and market saturation, firms like Truist Securities and Oppenheimer remain optimistic about Intuitive Surgical’s long-term growth potential. Truist updated its price target to $666, while Oppenheimer maintained a Perform rating, citing concerns over valuation and market saturation. The company also secured a significant €290 million distribution agreement to expand its presence in Europe, further enhancing its growth prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.